Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 162 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Keyword is Disease Progression  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Hadjigeorgiou, G. M., Doxani C., Miligkos M., Ziakas P., Bakalos G., Papadimitriou D., et al. (2013).  A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.. J Clin Pharm Ther. 38(6), 433-9.
Haider, L., Simeonidou C., Steinberger G., Hametner S., Grigoriadis N., Deretzi G., et al. (2014).  Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.. J Neurol Neurosurg Psychiatry. 85(12), 1386-95.
Haidopoulou, K., Calder A., Jones A., Jaffe A., & Sonnappa S. (2009).  Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function.. Pediatr Pulmonol. 44(7), 669-75.
Han, L. Y., Karavasilis V., van Hagen T., Nicum S., Thomas K., Harrison M., et al. (2010).  Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.. Eur J Cancer. 46(8), 1359-64.
Handels, R. L. H., Vos S. J. B., Kramberger M. G., Jelic V., Blennow K., van Buchem M., et al. (2017).  Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers.. Alzheimers Dement. 13(8), 903-912.
Hauser, S. L., Bar-Or A., Cohen J. A., Comi G., Correale J., Coyle P. K., et al. (2020).  Ofatumumab versus Teriflunomide in Multiple Sclerosis.. N Engl J Med. 383(6), 546-557.
Heinig, K., Gätjen M., Grau M., Stache V., Anagnostopoulos I., Gerlach K., et al. (2014).  Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.. Cancer Discov. 4(12), 1448-65.
Héron, B., Mikaeloff Y., Froissart R., Caridade G., Maire I., Caillaud C., et al. (2011).  Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece.. Am J Med Genet A. 155A(1), 58-68.
Hytiroglou, P., Kotoula V., Thung S. N., Tsokos M., Fiel M. I., & Papadimitriou C. S. (1998).  Telomerase activity in precancerous hepatic nodules.. Cancer. 82(10), 1831-8.
K
Kaiafa, G. D., Saouli Z., Diamantidis M. D., Kontoninas Z., Voulgaridou V., Raptaki M., et al. (2012).  Copper levels in patients with hematological malignancies.. Eur J Intern Med. 23(8), 738-41.
Kakaletsis, N., Kaiafa G., Savopoulos C., Iliadis F., Perifanis V., Tzalokostas V., et al. (2014).  Initially lymphocytic Sweet's syndrome in male patients with myelodysplasia: a distinguished clinicopathological entity? Case report and systematic review of the literature.. Acta Haematol. 132(2), 220-5.
Kakkos, S. K., Sabetai M., Tegos T., Stevens J., Thomas D., Griffin M., et al. (2009).  Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis.. J Vasc Surg. 49(4), 902-9.
Kakkos, S. K., Nicolaides A. N., Charalambous I., Thomas D., Giannopoulos A., A Naylor R., et al. (2014).  Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis.. J Vasc Surg. 59(4), 956-967.e1.
Karagiozoglou-Lampoudi, T., Trachana M., Agakidis C., Pratsidou-Gertsi P., Taparkou A., Lampoudi S., et al. (2011).  Ghrelin levels in patients with juvenile idiopathic arthritis: relation to anti-tumor necrosis factor treatment and disease activity.. Metabolism. 60(10), 1359-62.
Karalazou, P., Ntelios D., Chatzopoulou F., Fragou A., Taousani M., Mouzaki K., et al. (2019).  OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.. Ital J Pediatr. 45(1), 161.
Kastritis, E., Gavriatopoulou M., Roussou M., Migkou M., Fotiou D., Ziogas D. C., et al. (2017).  Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.. Am J Hematol. 92(7), 632-639.
Kastritis, E., Gavriatopoulou M., Kyrtsonis M-C., Roussou M., Hadjiharissi E., Symeonidis A., et al. (2015).  Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.. Blood. 126(11), 1392-4.
Katirtzoglou, N., Gkiozos I., Makrilia N., Tsaroucha E., Rapti A., Stratakos G., et al. (2010).  Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study.. Clin Lung Cancer. 11(1), 30-5.
Katopodi, T., Petanidis S., Domvri K., Zarogoulidis P., Anestakis D., Charalampidis C., et al. (2021).  Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.. Sci Rep. 11(1), 15455.
Katsoulis, K., Kontakiotis T., Gerou S., Kougioulis M., Lithoxopoulou H., & Papakosta D. (2010).  Alterations of erythrocyte superoxide dismutase activity in patients suffering from asthma attacks.. Monaldi Arch Chest Dis. 73(3), 99-104.
Kiddle, S. J., Sattlecker M., Proitsi P., Simmons A., Westman E., Bazenet C., et al. (2014).  Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.. J Alzheimers Dis. 38(3), 515-31.
Konstantinidis, I., Papageorgiou S. N., Kyrgidis A., Tzellos T-G., & Kouvelas D. (2013).  Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review.. Rev Recent Clin Trials. 8(1), 48-60.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.